Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

A letter to the US public on the AMA website, signed by 75+ medical societies, stresses the vital importance of influenza, ...

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

Chicago, June 09, 2025 (GLOBE NEWSWIRE) -- The global respiratory syncytial virus treatment market valued at USD 2,387.2 million in 2024 and is projected to reach USD 8,332.5 million by 2033 ...

Unlike IgG, which has two arms to bind a virus, IgM antibodies have ten. This pentameric shape gives them multivalency, meaning they can grab onto several parts of a virus at once.

The researchers found that the median preF IgG increased from 87,292 AU/mL at baseline to 626,280; 439,086; and 464,170 AU/mL at 2, 4, and 12 weeks postvaccination, respectively.

HealthDay News — For immunocompromised individuals, antibody response to respiratory syncytial virus (RSV) vaccines is heterogeneous and about 40 percent do not seroconvert, according to a research ...

TUESDAY, Jan. 7, 2025 (HealthDay News) -- For immunocompromised individuals, antibody response to respiratory syncytial virus (RSV) vaccines is heterogeneous and about 40 percent do not ...

Every year, millions of people worldwide are affected by a virus that often goes unnoticed -Respiratory Syncytial Virus (RSV). Despite its widespread prevalence, many people remain unaware of what RSV ...

Background In Catalonia, infants under 6 months old were eligible to receive nirsevimab, a novel monoclonal antibody against respiratory syncytial virus (RSV). We aimed to analyse nirsevimab’s ...